Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres - 23/12/20
, A. Hocquelet b, F. Debordeaux c, L. Bordenave c, d, J.-F. Blanc e, P. Papadopoulos a, B. Lapuyade a, H. Trillaud a, f, J.-B. Pinaquy c
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Highlights |
• | Cone-beam CT may be a reproductible and reliable method for perfused volume segmentation. |
• | Cone-beam CT does not significantly increase accuracy of dose prediction by comparison with 99mTc-MAA SPECT/CT. |
• | Cone-beam CT may be particularly appropriate if there are multiple injection sites or for radiation segmentectomy. |
Abstract |
Purpose |
To compare the reliability and accuracy of the pre-treatment dosimetry predictions using cone-beam computed tomography (CBCT) versus 99mTc-labeled macroaggregated albumin (MAA) SPECT/CT for perfused volume segmentation in patients with hepatocellular carcinoma treated by selective internal radiation therapy (SIRT) using 90Y-glass microspheres.
Materials and methods |
Fifteen patients (8 men, 7 women) with a mean age of 68.3±10.5 (SD) years (range: 47–82 years) who underwent a total of 17 SIRT procedures using 90Y-glass microspheres for unresectable hepatocellular carcinoma were retrospectively included. Pre-treatment dosimetry data were calculated from 99mTc-MAA SPECT/CT using either CBCT or 99mTc-MAA SPECT/CT to segment the perfused volumes. Post-treatment dosimetry data were calculated using 90Y imaging (SPECT/CT or PET/CT). The whole liver, non-tumoral liver, and tumor volumes were segmented on CT or MRI data. The mean absorbed doses of the tumor (DT), non-tumoral liver, perfused liver (DPL) and perfused non-tumoral liver were calculated. Intra- and interobserver reliabilities were investigated by calculating Lin's concordant correlation coefficients (ρc values). The differences (biases) between pre- and post-treatment dosimetry data were assessed using the modified Bland–Altman method (for non-normally distributed variables), and systematic bias was evaluated using Passing–Bablok regression.
Results |
The intra- and interobserver reliabilities were good-to-excellent (ρc: 0.80–0.99) for all measures using both methods. Compared with 90Y imaging, the median differences were 5.8Gy (IQR: −12.7; 16.1) and 5.6Gy (IQR: −13.6; 10.2) for DPL-CBCT and DPL-99mTc-MAA SPECT/CT, respectively. The median differences were 1.6Gy (IQR: −29; 7.53) and 9.8Gy (IQR: −28.4; 19.9) for DT-CBCT and DT-99mTc-MAA SPECT/CT respectively. Passing–Bablok regression analysis showed that both CBCT and 99mTc-MAA SPECT/CT had proportional biases and thus tendencies to overestimate DT and DPL at higher post-treatment doses.
Conclusion |
CBCT may be a reliable segmentation method, but it does not significantly increase the accuracy of dose prediction compared with that of 99mTc-MAA SPECT/CT. At higher doses both methods tend to overestimate the doses to tumors and perfused livers.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Brachytherapy, Radiation dosimetry, Yttrium-90, Carcinoma, hepatocellular, Cone-beam CT, SPECT CT
Abbreviations : 90Y, 95% CI, 99mTc, BCLC, CBCT, CD-CTHA, CT, ICC, HCC, MAA, MELD, MIRD, MRI, PET, Q1, Q3, SIRT, SPECT/CT, SD, T/N, VOI
Mappa
Vol 102 - N° 1
P. 45-52 - gennaio 2021 Ritorno al numero
Articolo precedente
- Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteria
- M. Ghosn, H. Derbel, R. Kharrat, N. Oubaya, S. Mulé, J. Chalaye, H. Regnault, G. Amaddeo, E. Itti, A. Luciani, H. Kobeiter, V. Tacher
- Percutaneous irreversible electroporation of porta hepatis lymph node metastasis
- Julien Garnon, Pierre Auloge, Danoob Dalili, Roberto L. Cazzato, Afshin Gangi
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.